Comparison of two drugs given along with local anaesthetic in an ultrasound guided procedure for pain relief in breast surgery

INTERVENTION: Intervention1: Buprenorphine and dexamethasone with 0.5% ropivacaine: patients will be observed postoperatively for duration till first analgesic request, total rescue analgesic consumption, pain score using VAS and any side effects in the form of nausea, vomiting, headache or sedation for 24 hours Control Intervention1: dexamethasone and buprenorphine: one group will receive 0.5% ropivacaine+ 150 mcg of buprenorphine. other group will receive 0.5% ropivacaine + 8 mg of dexamethasone in serratus anterior plane block CONDITION: Health Condition 1: O‐ Medical and Surgical PRIMARY OUTCOME: duration of analgesiaTimepoint: from the time of injection of drug in SAP block to the request for first rescue analgesia in PACU till 24 hours SECONDARY OUTCOME: 1. VAS ; 2. total postoperative opioid consumptionTimepoint: 1. at PACU,at 2,4,6,8,12,16,20,24 hours ; 2. at 24 hours postop. INCLUSION CRITERIA: patients belonging to ASA physical status I and II posted for oncological breast surgery with or without reconstruction with at least 24 hours hospital stay